1. 1- Cunningham FG. Leveno KJ. Bloom SL. Hauth JC. Gilstrap III. et al. Williams Obstetrics. 22 ed. MC Graw- Hill: New York: 2005. p. 536-537. 2- Mobasheri E, Jafarpour H, Rezaei A, Piraste Far Z, Bakhshi T. The Role Of Antibiotics Therapy On Maternal Complication In Women With Premature Rupture Of Membranes. 2017; 6(2): 53-58 3- Maslow AS. Sweeny AL. Elective induction of labor as a risk factor for cesarean delivery among low-risk women at term. Obstet Gyneocol 2000; 95: 917-922. 4- Smith KM. Hoffman MK. Sciscione A. Elective induction of labor in nulliparous women increases the risk of cesarean delivery. Obstet Gynecol 2003; 101: 455. 5- Hinshaw K, Simpson S, Cummings S, Hildreth A, Thornton J. A Andomized Controlled Trial Of Early Versus Delayed Oxytocin Augmentation To Treat Primary Dysfunctional Labour In Nulliparous Women. BJOG 2008; 115(10):1289-95. 6- American College of Obstetrics, Gynecology Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin Number 49, December 2003; Dystocia and Augmentation of Labor. Obstet Gynecol 2003; 102:1445- 54. 7- O’Driscoll K, Foley M, Macdonald D. Active Management of Labor as an Alternative to Cesarean Section for Dystocia. Obstet Gynecol 1984; 63:485-90. 8- Schuitemaker N, Van Roosmalen J, Dekker G, Van Dongen P, Van Geijn H, Gravenhorst JB. Maternal Mortality after Cesarean Section in the Netherlands. Acta Obstet Gynecol Scand 1997; 76:332 4. 9- Hemlin J. Moller B. Extraamniotic saline infusion is promising in preparing the cervix for induction of labor. Acta Obstet Gynecol Scand 1998; 77: 45-9. 10- Kashanian M, Zarin Z . Comparison of the effect of oxytocin alone and the administration of oxytocin-propranolol on the onset of labor - A randomized, double-blind study. Feyz Scientific-Research Quarterly. 10 (2): 7-11 11- Sharami S. H, et al. Effect of Oxytocin Plus Propranolol on The Success of Labor Augmentation. Journal of Guilan University of Medical Sciences, No: 82, Pages: 57-64 12- Ashraf Direkvand Moghadam et al., Comparison Effect of Oral Propranolol and Oxytocin Versus Oxytocin only on Induction of Labor, Journal of Clinical and Diagnostic Research. 2013 Nov, Vol-7(11): 2567-2569 13- Direkvand-Moghadam A, Jaafarpour M, Khani A, Taheri S, Delpisheh A. Theeffect of oral propranolol plus oxytocin versus oxytocin only on the process and outcome of labor: A double-blind randomized trial. Iran J Nurs Midwifery Res. 2014 Sep;19(5):491-5. 14- Ziółkowski K. Induction of Labor in Prolonged Pregnancy with Propranolol as a Personal Evaluation. Pol Tyg Lek 1994; 49(8-9):184-5. 15- Palomäki O, Uotila J, Tammela O, Kaila T, Lavapuro M, Huhtala H, Tuimala R. A Double Blind, Randomized Trial on Augmentation of Labour with A Combination of Intravenous Propranolol and Oxytocin Versus Oxytocin Only. Eur J Obstet Gynecol Reprod Biol 2006; 125(1):44-9. 16- Mitrani A, Oettinger M, Abinader EG, Sharf M, Klein A. Use of Propranolol in Dysfunctional Labour. Br J Obstet Gynaecol 1975; 82(8):651-5. 17- Flier JS. Underhill LH. Adrenergic Receptors- Evolving Concepts and Clinical Implications. N Engl J Med 1996; 334: 580. 18- Dennedy MC. Houlihan DD. Mc Millan H. Morrison JJ. Beta 2-and beta3- adrenoreceptor agonists: human Myometrial selectivity and effects on umbilical artery tone. Am J Obstet Gynecol 2002; 187: 641-647. 19- Chanrachakul B. Matharoo-Ball B. Turner A. Robinson G. Broughton-Pipkin F. Arulkumaran S. et al. Reduced expression of immunoreactive beta2-adrenergic receptor protein in human myometrium with labor. J Clin Endocrinol Metab 2003; 88: 4997-5001. 20- Bardou M. Loustalot C. Cortijo J. Simon B. Naline E. Dumas M. Et al. Functional, biochemical and molecular biological evidence for a possible beta (3)-adrenoceptor in human near-term myometrium. Br J Pharmacol 2000; 130: 1960-1966. 21- Rouget C. Bardou M. Breuiller- Fouche M. Loustalot C. Qi H. Naline E. Et al. Beta 3-adrenoceptor is the predominant beta-adrenoceptor subtype in human myometrium and its expression is up-regulated in pregnancy. J Clin Endocrinol Metab 2005; 90: 1644-1650. 22- Ingarden J. Dubiel A. Rauluszkiewicz S. The effect of administration of a beta blocker in periparturient mares. Equine Vet J Suppl 1998; 27: 19-20. 23- Pergialiotis V, Frountzas M, Prodromidou A, Prapa S, Perrea DN, Vlachos GD. Propranolol and oxytocin versus oxytocin alone for induction and augmentation of labor: a meta-analysis of randomized trials. Arch Gynecol Obstet. 2016 Apr;293(4):721-9. 24- Outi Paloma¨ki , Jukka Uotila , Outi Tammela , Timo Kaila, Merja Lavapuro , Heini Huhtala , Risto Tuimala. A double blind, randomized trial on augmentation of labour with a combination of intravenous propranolol and oxytocin versus oxytocin only. European Journal of Obstetrics & Gynecology and Reproductive Biology 125 (2006) 44–49. 25- American College of Obstetrics, Gynecology Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin number 49, December 2003: dystocia and augmentation of labor. Obstet Gynecol 2003;102:1445–54. 26- Ha¨ger RM, Daltveit AK, Hofoss D, Nilsen ST, Kolaas T, Oian P, et al.Complications of Cesarean deliveries: rates and risk factors. Am J Obstet Gynecol 2004;190:428–34. 27- Jackson N, Paterson-Brown S. Physical sequelae of caesarean section. Best Pract Res Clin Obstet Gynaecol 2001;15:49–61. 28- Schuitemaker N, van Roosmalen J, Dekker G, van Dongen P, van Geijn H, Gravenhorst JB. Maternal mortality after Cesarean section in the Netherlands. Acta Obstet Gynecol Scand 1997;76:332–4. 29- Sanchez-Ramos L, Quillen MJ, Kaunitz AM. Randomized trial of oxytocin alone and with propranolol in the management of dysfunctional labor. Obstet Gynecol 1996;88:517–20. 30- Katzung BG. Clinical Pharmacology. Philadelphia; Appletone, 1998.